Stocktoria
AbbVie Inc. ABBV
AbbVie Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $61.2B | $56.3B | $54.3B | $58.1B | $56.2B | $45.8B | $33.3B | $32.8B | $28.2B | $25.6B |
| SG&A expense | $14.0B | $14.8B | $12.9B | $15.3B | $12.3B | $11.3B | $6.9B | $7.4B | $6.3B | $5.9B |
| Operating income | $15.1B | $9.1B | $12.8B | $18.1B | $17.9B | $11.4B | $13.0B | $6.4B | $9.5B | $9.3B |
| Interest expense | $2.9B | $2.8B | $2.2B | $2.2B | $2.4B | $2.5B | $1.8B | $1.3B | $1.1B | $1.0B |
| Income tax | $2.4B | -$570.0M | $1.4B | $1.6B | $1.4B | -$1.2B | $544.0M | -$490.0M | $2.4B | $1.9B |
| Net income | $4.2B | $4.3B | $4.9B | $11.8B | $11.5B | $4.6B | $7.9B | $5.7B | $5.3B | $6.0B |
| EPS (diluted) | $2.36 | $2.39 | $2.72 | $6.63 | $6.45 | $2.72 | $5.28 | $3.66 | $3.30 | $3.63 |
| Operating cash flow | $19.0B | $18.8B | $22.8B | $24.9B | $22.8B | $17.6B | $13.3B | $13.4B | $10.0B | $7.0B |
| Free cash flow | $17.8B | $17.8B | $22.1B | $24.2B | $22.0B | $16.8B | $12.8B | $12.8B | $9.4B | $6.6B |
| Cash & equivalents | $5.2B | $5.5B | $12.8B | $9.2B | $9.7B | $8.4B | $39.9B | $7.3B | $9.3B | $5.1B |
| Inventory | $5.0B | $4.2B | $4.1B | $3.6B | $3.1B | $3.3B | $1.8B | $1.6B | $1.6B | $1.4B |
| Total assets | $134.0B | $135.2B | $134.7B | $138.8B | $146.5B | $150.6B | $89.1B | $59.4B | $70.8B | $66.1B |
| Shareholders' equity | -$3.3B | $3.4B | $10.4B | $17.3B | $15.4B | $13.1B | -$8.2B | -$8.4B | $5.1B | $4.6B |
Growth · year-over-year · Revenue CAGR 10.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +8.6% | +3.7% | -6.4% | +3.3% | +22.7% | +37.7% | +1.6% | +16.1% | +10.1% | +12.2% |
| Net income growth | -1.2% | -12.0% | -58.9% | +2.5% | +150.0% | -41.4% | +38.6% | +7.1% | -10.8% | +15.7% |
| EPS growth | -1.3% | -12.1% | -59.0% | +2.8% | +137.1% | -48.5% | +44.3% | +10.9% | -9.1% | +16.0% |
| Free cash flow growth | -0.1% | -19.2% | -9.0% | +10.3% | +31.0% | +31.5% | -0.1% | +35.6% | +43.7% | -6.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.